Science News

... from universities, journals, and other research organizations

Renal Transplantation Is Best Treatment Option for Improving Quality of Life in People With Late-Stage Chronic Kidney Disease

Sep. 11, 2012 — In people with late-stage chronic kidney disease, renal transplantation is the best treatment option to improve quality of life, but for those receiving dialysis, home-based automated peritoneal dialysis (in which fluids are infused into the abdominal cavity and can be done nightly at home) provides a better quality of life than continuous ambulatory peritoneal dialysis (a type of dialysis performed continuously throughout the day), according to a study by Australian researchers published in this week's PLoS Medicine.


Share This:

The researchers, led by Melanie Wyld from the University of Sydney, reviewed and assimilated all of the available published evidence to investigate whether quality of life in people with late-stage chronic kidney disease (as measured by utilities -- a numerical value measured on a 0 to 1 scale [where 0 represents death and 1 represents full health] of the strength of an individual's preference for specified health-related outcomes) differed according to treatment type.

In their analysis, which represented over 56,000 patients, the researchers found that the average utility for those who had a renal transplantation was 0.82, followed by the pre-dialysis group (0.79), patients treated with dialysis (0.70), and finally, patients receiving conservative care (0.62). When comparing the type of dialysis, the researchers found that there was no significant difference in utilities between haemodialysis and peritoneal dialysis, but patients using automated peritoneal dialysis had, on average, a higher utility (0.80) than those treated with continuous ambulatory peritoneal dialysis (0.72).

In addition to helping to inform economic evaluations of treatment options, the information from this analysis can help guide clinicians caring for patients with chronic kidney disease in their discussions about possible treatment options.

The authors conclude: "Our results suggest that automated peritoneal dialysis, a home-based form of dialysis that accounts for just 7% of dialysis patients in the UK and 4% of dialysis patients in the United States, has a significantly higher mean utility than continuous ambulatory peritoneal dialysis."

Commenting on the findings, the authors said: "The finding that transplant patients' utilities increased significantly between the 1980s and the 2000s likely reflects improvements in transplant care and evolving clinical practice."

They add: "We found that patients who chose conservative care had significantly lower quality of life than patients treated with dialysis, although the number of studies was small."

Share this story on Facebook, Twitter, and Google:

Other social bookmarking and sharing tools:

|

Story Source:

The above story is reprinted from materials provided by Public Library of Science.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


Journal Reference:

  1. Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLoS Medicine, 2012; 9 (9): e1001307 DOI: 10.1371/journal.pmed.1001307
APA

MLA

Note: If no author is given, the source is cited instead.

Search ScienceDaily

Number of stories in archives: 137,250

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily's archives for related news topics,
the latest news stories, reference articles, science videos, images, and books.

Recommend ScienceDaily on Facebook, Twitter, and Google:

Other social bookmarking and sharing services:

|

 
  more breaking science news

Social Networks


Recommend ScienceDaily on Facebook, Twitter, and Google +1:

Other social bookmarking and sharing tools:

|

Breaking News

... from NewsDaily.com

In Other News ...

Science Video News


No More Dialysis

A nephrologist has found that a specialized type of anti-rejection therapy using intravenous immunoglobulin can make kidney transplants possible for. ...  > full story

Strange Science News

 

Free Subscriptions

... from ScienceDaily

Get the latest science news with our free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Feedback

... we want to hear from you!

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?

Post this page to your favorite social bookmarking site:
Include this item in your blog or web site:
Cite this article in your essay, paper, or report:
Email this page's link to a friend or colleague: